The Omnipod maker purchased assets related to Bigfoot Biomedical’s pump-based automated insulin delivery technology.
Insulet acquires Bigfoot’s insulin pump patents for $25M

The Omnipod maker purchased assets related to Bigfoot Biomedical’s pump-based automated insulin delivery technology.